Phio Pharmaceuticals Corp (NAS:PHIO) Stock News, Headlines & Updates
Phio Pharmaceuticals Corp Stock News from GuruFocus
- 1
Jun 25, 2025
PHIO: HC Wainwright Reiterates Buy Rating for Phio Pharma | PHIO Stock News
GuruFocus News • 10:30am
Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Clinical Trial to Fifth Dose Escalation Cohort | PHIO Stock News
GuruFocus News • 7:00am
Jun 24, 2025
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series | PHIO Stock News
GuruFocus News • 7:00am
Jun 06, 2025
Phio Pharmaceuticals Announces Strategic Initiative to Create Awareness of the Comprehensive INTASYL siRNA Portfolio | PHIO Stock News
GuruFocus News • 7:00am
Jun 05, 2025
Phio Pharma (PHIO) Receives Buy Rating and $14 Price Target from HC Wainwright | PHIO Stock News
GuruFocus News • 6:30am
Phio Pharmaceuticals (PHIO) Gains 'Buy' Rating with Promising Price Target | PHIO Stock News
GuruFocus News • 5:30am
May 19, 2025
Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference | PHIO Stock News
GuruFocus News • 7:00am
May 15, 2025
Phio Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update | PHIO Stock News
GuruFocus News • 3:31pm
May 07, 2025
Phio Pharmaceuticals Announces Positive Pathology Results in Third Cohort in INTASYL PH-762 Skin Cancer Clinical Trial | PHIO Stock News
GuruFocus News • 7:00am
May 01, 2025
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series | PHIO Stock News
GuruFocus News • 7:15am
Apr 09, 2025
- 1
Show
Entries
Headlines
Total 0- 1
No recent news